Lymph node tuberculosis as primary manifestation of Hodgkin's disease;Lymphknotentuberkulose als erstmanifestation eines morbus Hodgkin

Medizinische Klinik

Volumn 101, Issue 6, 2006, Pages 500-504

  Audebert, Franz ^b   Schneidewind, Arne ^c   Hartmann, Pia ^c   Kullmann, Frank ^c   Schölmerich, Jürgen ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c NONE

Author keywords

Hodgkin's disease; Lymphogranulomatosis; MDR TB multiple drug resistance; TB; Tuberculosis

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ABDOMEN; ACID FAST BACTERIUM; ADULT; ANAMNESIS; ARTICLE; AXILLARY LYMPH NODE; CANCER CHEMOTHERAPY; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE COURSE; DYSPNEA; FEMALE; HODGKIN DISEASE; HOSPITAL ADMISSION; HUMAN; LYMPH NODE BIOPSY; MASTITIS; MEDIASTINUM LYMPH NODE; NECK; NIGHT SWEAT; PARAAORTIC LYMPH NODE; PLEURA EFFUSION; SYMPTOMATOLOGY; THORAX; TUBERCULOUS LYMPHADENITIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTITUBERCULAR AGENTS; BIOPSY; BLEOMYCIN; DACARBAZINE; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DOXORUBICIN; HODGKIN DISEASE; HUMANS; LYMPH NODES; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, MULTIDRUG-RESISTANT; VINBLASTINE;

BACILLI (CLASS);

EID: 33745147618     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-006-1071-3     Document Type: Article

References (33)

1. Abraham E, Anzueto A, Gutierrez G, et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 1998;351:929-33.
2. Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNT-alpha MAb Sepsis Study Group. JAMA 1995;273:934-41.
3. Advani SH, D'Silva H, Gothoskar BP, et al. Cellular immunity in Hodgkin's disease. Cancer 1979;43:492-9.
4. Anonymus. Zur Situation bei wichtigen Infektionskrankheiten in Deutschland: Tuberkulose im Jahr 2003. Epidemiol Bull 2004;44:375-82.
5. Bartoli JM, Poncet M, Harle JR, et al. Hepatic tuberculosis after Hodgkin's disease. Echographic and x-ray computed tomographic aspects. A case report. J Radiol 1990;71:663-5.
6. Bobrove AM, Fuks Z, Strober S, et al. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer 1975;36:169-79.
7. Centkowski P, Sawczuk-Chabin J, Prochorec M, et al. Hodgkin's lymphoma and tuberculosis coexistence in cervical lymph nodes. Leuk Lymphoma 2005;46:471-5.
8. Cho S, Mehra V, Thoma-Uszynski S, et al. Antimicrobial activity oi MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A 2000;97:12210-5.
9. Cooper AM, Dalton DK, Stewart TA, et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993;178:2243-7.
10. Costa LJ, Gallafrio CT, Franca FO, et al. Simultaneous occurrence of Hodgkin disease and tuberculosis: report of three cases. South Med J 2004;97:696-8.
11. Decludt B, Campese C. Les cas de tuberculose déclarés en France 2000. Bull Epidemiol Hebd 2002;16:68-70.
12. DiBella NJ, Buchanan BD, Koontz CH. Disseminated atypical tuberculosis - antedating the clinical onset of neoplasia. Cancer 1977;40:1276-9.
13. Feng CG, Bean AG, Hooi H, et al. Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect Immun 1999;67:3242-7.
14. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129.
15. Flynn JL, Goldstein MM, Triebold KJ, et al. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A 1992;89:12013-7.
16. Graeme-Cook F, O'Briain DS, Daly PA. Unusual breast masses. The sequential development of mammary tuberculosis and Hodgkin's disease in a young woman. Cancer 1988;61:1457-9.
17. Han T. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease. Cancer 1980;45:2102-8.
18. Hartmann P, Plum G. Immunological defense mechanisms in tuberculosis and MAC-infection. Diagn Microbiol Infect Dis 1999;34:147-52.
19. Holm G, Mellstedt H, Bjorkholm M, et al. Lymphocyte abnormalities in untreated patients with Hodgkin's disease. Cancer 1976;37:751-62.
20. Kalaria VG, Kapila R, Schwartz RA. Tuberculous gumma (cutaneous metastatic tuberculous abscess) with underlying lyuiphoma. Cutis 2000;66:277-9.
21. Karakas Z, Agaoglu L, Taravari B, et al. Pulmonary tuberculosis in children, with Hodgkin's lymphoma. Hematol J 2003;4:78-81.
22. Kim KW, Park SY, Lee EH, et al. Mucosa-associated lymphoid tissue (MALT) lymphoma combined with tuberculous enteritis at the same site in the jejunum. Leuk Lymphoma 2001;42:1151-5.
23. Konietzko N, Loddenkemper R. Tuberkulose. Stuttgart: Thieme, 1999.
24. Libshitz HI, Pannu HK, Elting LS, et al. Tuberculosis in cancer patients: an update. J Thorac Imaging 1997;12:41-6.
25. Muller K, Fopp M, Senn HJ. Unrecognized atypical tuberculosepsis in generalized hematologic neoplasms. Schweiz Med Wochenschr 1980;110:1815-7.
26. Ouedraogo M, Ouedraogo SM, Cisse R, et al. Active tuberculosis in a patient with Hodgkin's disease. A case report. Rev Pneumol Clin 2000;56:33-5.
27. Ozguroglu M, Celik AF, Demir G, et al. Primary splenic tuberculosis in a patient with nasal angiocentric lymphoma: mimicking metastatic tumor on abdominal CT. J Clin Gastroenterol 1999;29:96-8.
28. Poppema S. Immunology of Hodgkin's disease. Baillieres Clin Haematol 1996;9:447-57.
29. Raja A. Immunology of tuberculosis. Indian J Med Res 2004;120:213-32.
30. Serbina NV, Liu CC, Scanga CA, et al. CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. J Immunol 2000;165:353-63.
31. Slivnick DJ, Ellis TM, Nawrocki JF, et al. The impact of Hodgkin's disease on the immune system. Semin Oncol 1990;17:673-82.
32. Twomey JJ, Laughter AH, Farrow S, et al. Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest 1975;56:467-75.
33. Van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002;15:294-309.